# Glossary

Key terms used in benefit-risk assessment.

## A-D

**Benefit**
: A favorable effect of a medicinal product.

**Benefit-Risk Assessment (BRA)**
: Systematic evaluation of the benefits and risks of a medicine.

**BRAD**
: Benefit-Risk Action Document. A standardized template for documenting B-R evaluations.

**CIOMS**
: Council for International Organizations of Medical Sciences.

**Composite Endpoint**
: A clinical trial endpoint combining multiple outcomes.

**DOOR**
: Desirability of Outcome Ranking. A method for analyzing composite endpoints.

## E-M

**Effects Table**
: Structured presentation of benefits and risks with quantitative data.

**MCDA**
: Multi-Criteria Decision Analysis. Quantitative method for B-R evaluation.

**MedDRA**
: Medical Dictionary for Regulatory Activities.

## N-S

**NNT**
: Number Needed to Treat.

**NNH**
: Number Needed to Harm.

**RMM**
: Risk Minimization Measure.

**SBRF**
: Structured Benefit-Risk Framework.

## T-Z

**Value Tree**
: Hierarchical representation of benefit and risk factors.

**Win Ratio**
: In DOOR analysis, the ratio of treatment wins to control wins.
